Ticker LaunchFiled, not priced · NUOX
NuvOx Therapeutics, Inc.
NuvOx Therapeutics, Inc. publicly filed a registration statement on Form S-1 on Jul 17, 2026 for a proposed initial public offering on NYSE American under the ticker NUOX, and has not yet priced. Its latest amendment was filed on Oct 13, 2026. Underwriters named in the filing: ThinkEquity.
NuvOx Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing oxygen therapeutics for diseases involving hypoxia. Its candidate NanO2, whose active ingredient is dodecafluoropentane, is an intravenous emulsion that delivers oxygen.
- Status
- Filed, not priced
- Ticker
- NUOX
- Exchange
- NYSE American
- First filed
- Jul 17, 2026
- Latest amendment
- Oct 13, 2026
- Underwriters
- ThinkEquity
- Sector
- Biotech & pharma
- Country / state
- AZ
More on this listing for subscribers
- Shares offered, over-allotment and shares outstanding after the offering
- Amendment history
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Registration statement (S-1) first filed Jul 17, 2026
- Latest amendment Oct 13, 2026
- All filings on EDGAR CIK 1966126
Other companies in the IPO pipeline
- Londonla Inc.Jul 20, 2026
- RZ Wellness LtdJul 20, 2026
- Sin Lian Seng ConstructionJul 10, 2026
- Timwood Holdings LtdJul 10, 2026
- Tailored Brands, Inc. / DEJul 10, 2026
- Syntiant Corp.Jul 6, 2026